Published in J Virol on May 01, 2013
A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy. Blood (2013) 1.03
Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3). Mol Cell Proteomics (2015) 0.88
Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans. Sci Rep (2016) 0.81
Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells. Immunology (2015) 0.77
Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play. Emerg Microbes Infect (2016) 0.76
Affinity of human IgG subclasses to mouse Fc gamma receptors. MAbs (2017) 0.75
Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection. Virulence (2016) 0.75
In vitro enhancement of RSV infection by maternal antibodies does not explain disease severity in infants. J Virol (2017) 0.75
Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics (1998) 49.00
Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med (1992) 22.13
Evidence based selection of housekeeping genes. PLoS One (2007) 7.90
FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell (1994) 7.66
Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child (1986) 7.39
Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med (1999) 5.55
Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J Infect Dis (1997) 3.88
Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis (1991) 3.27
Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies. Int Immunol (2001) 2.87
Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity (2004) 2.79
The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. J Immunol Methods (1998) 2.78
The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan. J Exp Med (2003) 2.63
A role for immune complexes in enhanced respiratory syncytial virus disease. J Exp Med (2002) 2.34
Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung. J Exp Med (2002) 2.32
Sequences and repertoire of the human T cell receptor alpha and beta chain variable region genes in thymocytes. Eur J Immunol (1987) 2.32
FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity (2002) 2.31
Increasing the affinity of a human IgG1 for the neonatal Fc receptor: biological consequences. J Immunol (2002) 2.00
Diagnosis of respiratory syncytial virus infection: comparison of reverse transcription-PCR to viral culture and serology in adults with respiratory illness. J Clin Microbiol (2002) 1.92
Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies. Vaccine (2003) 1.83
Dependence of antibody-mediated presentation of antigen on FcRn. Proc Natl Acad Sci U S A (2008) 1.82
Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway. Proc Natl Acad Sci U S A (2004) 1.69
Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo. J Immunol (2002) 1.66
Mapping the site on human IgG for binding of the MHC class I-related receptor, FcRn. Eur J Immunol (1999) 1.61
Efficient mucosal vaccination mediated by the neonatal Fc receptor. Nat Biotechnol (2011) 1.47
Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells. Proc Natl Acad Sci U S A (2011) 1.44
Respiratory syncytial virus-induced activation and migration of respiratory dendritic cells and subsequent antigen presentation in the lung-draining lymph node. J Virol (2009) 1.43
Disease severity and viral load are correlated in infants with primary respiratory syncytial virus infection in the community. J Med Virol (2010) 1.40
Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1. J Immunol (1997) 1.39
Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin. J Infect Dis (1994) 1.34
FcRn: an IgG receptor on phagocytes with a novel role in phagocytosis. Blood (2006) 1.30
Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial. Pediatrics (2009) 1.26
Respiratory syncytial virus specific serum antibodies in infants under six months of age: limited serological response upon infection. J Med Virol (1997) 1.24
How innate immune mechanisms contribute to antibody-enhanced viral infections. Clin Vaccine Immunol (2010) 1.23
Upon dendritic cell (DC) activation chemokines and chemokine receptor expression are rapidly regulated for recruitment and maintenance of DC at the inflammatory site. Int Immunol (1999) 1.20
Targeting the neonatal fc receptor for antigen delivery using engineered fc fragments. J Immunol (2008) 1.20
Respiratory syncytial virus infects and abortively replicates in the lungs in spite of preexisting immunity. J Virol (2007) 1.18
Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential. Nat Commun (2011) 1.11
Induction of type I interferons and interferon-inducible Mx genes during respiratory syncytial virus infection and reinfection in cotton rats. J Gen Virol (2008) 1.03
Characterization of the CD8+ T cell responses directed against respiratory syncytial virus during primary and secondary infection in C57BL/6 mice. Virology (2006) 1.02
The neonatal FcR-mediated presentation of immune-complexed antigen is associated with endosomal and phagosomal pH and antigen stability in macrophages and dendritic cells. J Immunol (2011) 0.99
Immune complex and Fc receptor-mediated augmentation of antigen presentation for in vivo Th cell responses. J Immunol (2000) 0.99
Multiplex screening for functionally rearranged immunoglobulin variable regions reveals expression of hybridoma-specific aberrant V-genes. J Immunol Methods (2001) 0.95
Serum antibodies critically affect virus-specific CD4+/CD8+ T cell balance during respiratory syncytial virus infections. J Immunol (2010) 0.88
Neutralizing and enhancing activities of human respiratory syncytial virus-specific antibodies. Clin Diagn Lab Immunol (1996) 0.88
Local innate and adaptive immune responses regulate inflammatory cell influx into the lungs after vaccination with formalin inactivated RSV. Vaccine (2011) 0.87
Antibody-dependent enhancement, a possible mechanism in augmented pulmonary disease of respiratory syncytial virus in the Bonnet monkey model. J Infect Dis (2003) 0.86
Molecular requirements for trinitrophenyl recognition by antihapten cytotoxic T lymphocytes. Cell Immunol (1980) 0.76
Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming. Nat Med (2009) 2.03
Respiratory syncytial virus-specific CD8+ memory T cell responses in elderly persons. J Infect Dis (2005) 1.48
Respiratory syncytial virus-induced activation and migration of respiratory dendritic cells and subsequent antigen presentation in the lung-draining lymph node. J Virol (2009) 1.43
Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells. J Immunol (2005) 1.30
CD8+ T cell responses in bronchoalveolar lavage fluid and peripheral blood mononuclear cells of infants with severe primary respiratory syncytial virus infections. J Immunol (2007) 1.26
A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants. J Virol (2009) 1.24
Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens. J Proteome Res (2009) 1.24
Macrophages eliminate circulating tumor cells after monoclonal antibody therapy. J Clin Invest (2014) 1.21
Activation and inactivation of antiviral CD8 T cell responses during murine pneumovirus infection. J Immunol (2005) 1.18
Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential. Nat Commun (2011) 1.11
Lack of CD200 enhances pathological T cell responses during influenza infection. J Immunol (2009) 1.11
Central role of complement in passive protection by human IgG1 and IgG2 anti-pneumococcal antibodies in mice. J Immunol (2003) 1.10
Genetic variability among complete human respiratory syncytial virus subgroup A genomes: bridging molecular evolutionary dynamics and epidemiology. PLoS One (2012) 1.06
Dynamics of human respiratory virus-specific CD8+ T cell responses in blood and airways during episodes of common cold. J Immunol (2008) 1.06
A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy. Blood (2013) 1.03
Human CD8(+) T cell responses against five newly identified respiratory syncytial virus-derived epitopes. J Gen Virol (2004) 1.02
Residues Arg568 and Phe592 contribute to an antigenic surface for anti-ADAMTS13 antibodies in the spacer domain. Haematologica (2011) 1.02
Characterization of the CD8+ T cell responses directed against respiratory syncytial virus during primary and secondary infection in C57BL/6 mice. Virology (2006) 1.02
The association between intrauterine inflammation and spontaneous vaginal delivery at term: a cross-sectional study. PLoS One (2009) 1.02
The role of Toll-like receptors in regulating the immune response against respiratory syncytial virus. Crit Rev Immunol (2009) 1.01
The comparative genomics of human respiratory syncytial virus subgroups A and B: genetic variability and molecular evolutionary dynamics. J Virol (2013) 1.01
IgG subclasses of anti-FVIII antibodies during immune tolerance induction in patients with hemophilia A. Br J Haematol (2008) 0.99
Distinct abnormalities in the innate immune system of children with Down syndrome. J Pediatr (2010) 0.97
Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing. Blood (2002) 0.92
CD200 receptor controls sex-specific TLR7 responses to viral infection. PLoS Pathog (2012) 0.92
Protection by meningococcal outer membrane protein PorA-specific antibodies and a serogroup B capsular polysaccharide-specific antibody in complement-sufficient and C6-deficient infant rats. Infect Immun (2006) 0.92
Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G. Glycoconj J (2012) 0.91
Dynamics of inter-heavy chain interactions in human immunoglobulin G (IgG) subclasses studied by kinetic Fab arm exchange. J Biol Chem (2014) 0.89
H435-containing immunoglobulin G3 allotypes are transported efficiently across the human placenta: implications for alloantibody-mediated diseases of the newborn. Transfusion (2013) 0.89
Staphylococcus aureus formyl peptide receptor-like 1 inhibitor (FLIPr) and its homologue FLIPr-like are potent FcγR antagonists that inhibit IgG-mediated effector functions. J Immunol (2013) 0.88
Serum antibodies critically affect virus-specific CD4+/CD8+ T cell balance during respiratory syncytial virus infections. J Immunol (2010) 0.88
Specific dietary oligosaccharides increase Th1 responses in a mouse respiratory syncytial virus infection model. J Virol (2012) 0.88
Contact and respiratory sensitizers can be identified by cytokine profiles following inhalation exposure. Toxicology (2009) 0.87
Local innate and adaptive immune responses regulate inflammatory cell influx into the lungs after vaccination with formalin inactivated RSV. Vaccine (2011) 0.87
Identification of a CD4 T cell epitope in the pneumonia virus of mice glycoprotein and characterization of its role in protective immunity. Virology (2007) 0.87
Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn. Br J Haematol (2014) 0.85
Role of leukocyte immunoglobuin G receptors in vaccine-induced immunity to Streptococcus pneumoniae. J Infect Dis (2003) 0.85
Inside-out regulation of Fc alpha RI (CD89) depends on PP2A. J Immunol (2008) 0.85
HLA-DP4 presents an immunodominant peptide from the RSV G protein to CD4 T cells. Virology (2004) 0.84
Expression of human CEACAM1 in transgenic mice limits the Opa-specific immune response against meningococcal outer membrane vesicles. Vaccine (2013) 0.83
Trimellitic anhydride-conjugated serum albumin activates rat alveolar macrophages in vitro. J Occup Med Toxicol (2006) 0.83
Coupling porous sheathless interface MS with transient-ITP in neutral capillaries for improved sensitivity in glycopeptide analysis. Electrophoresis (2013) 0.83
Antibodies and their receptors: different potential roles in mucosal defense. Front Immunol (2013) 0.82
Alveolar macrophages have a dual role in a rat model for trimellitic anhydride-induced occupational asthma. Toxicol Appl Pharmacol (2005) 0.82
Respiratory syncytial virus induced type I IFN production by pDC is regulated by RSV-infected airway epithelial cells, RSV-exposed monocytes and virus specific antibodies. PLoS One (2013) 0.82
Crystal structure of an Anti-meningococcal subtype P1.4 PorA antibody provides basis for peptide-vaccine design. J Mol Biol (2005) 0.82
Functional platelet defects in children with severe chronic ITP as tested with 2 novel assays applicable for low platelet counts. Blood (2014) 0.82
Label-free cell profiling. Anal Biochem (2013) 0.80
Pathogenicity of IgG subclass autoantibodies to type VII collagen: induction of dermal-epidermal separation. J Autoimmun (2009) 0.80
The respiratory local lymph node assay as a tool to study respiratory sensitizers. Toxicol Sci (2008) 0.80
Immunoglobulin A: Fc(alpha)RI interactions induce neutrophil migration through release of leukotriene B4. Gastroenterology (2009) 0.80
Preexposure to amorphous silica particles attenuates but also enhances allergic reactions in trimellitic anhydride-sensitized brown Norway rats. Inhal Toxicol (2008) 0.80
Prophylactic anti-D preparations display variable decreases in Fc-fucosylation of anti-D. Transfusion (2014) 0.80
An IgG3 switch variant of rituximab mediates enhanced complement-dependent cytotoxicity against tumour cells with low CD20 expression levels. Br J Haematol (2013) 0.78
The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases. Cell Mol Life Sci (2010) 0.78
Alveolar macrophages suppress non-specific inflammation caused by inhalation challenge with trimellitic anhydride conjugated to albumin. Arch Toxicol (2006) 0.78
Influencing mucosal homeostasis and immune responsiveness: the impact of nutrition and pharmaceuticals. Eur J Pharmacol (2011) 0.78
Signaling through mutants of the IgA receptor CD89 and consequences for Fc receptor gamma-chain interaction. J Immunol (2006) 0.77
The contact allergen dinitrochlorobenzene (DNCB) and respiratory allergy in the Th2-prone Brown Norway rat. Toxicology (2008) 0.77
Molecular analysis of the York antigen of the Knops blood group system. Transfusion (2011) 0.77
Escherichia coli bacteriuria in female adults is associated with the development of hypertension. Int J Infect Dis (2009) 0.76
Corrigendum: Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming. Nat Med (2016) 0.75